Jon E. Arnason
Impact in
Papers in
- Genetics 39
- Chronic Lymphocytic Leukemia Research 38
- Hematology 39
- Chronic Myeloid Leukemia Treatments 12
- Multiple Myeloma Research and Treatments 10
- Co-authors
- Tim D. Sparwasser (2 shared papers)Christoph Loddenkemper (1 shared paper)Alf Hamann (1 shared paper)Katharina Lahl (1 shared paper)Jennifer Freyer (1 shared paper)Gérard Eberl (1 shared paper)Jochen Huehn (1 shared paper)Hermann Wagner (1 shared paper)
- Journals
- Blood (51 papers)Transplantation and Cellular Therapy (12 papers)Blood Advances (8 papers)British Journal of Haematology (4 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- United StatesIsraelGermany
In The Last Decade
Jon E. Arnason
117 papers receiving 6.3k citations
Jon E. Arnason's Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 3.8k
- Genetics 1.0k
- Pathology and Forensic Medicine 1.6k
- Immunology 1.9k
- Hematology 788
Countries citing papers authored by Jon E. Arnason
This map shows the geographic impact of Jon E. Arnason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon E. Arnason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon E. Arnason more than expected).
Fields of papers citing papers by Jon E. Arnason
This network shows the impact of papers produced by Jon E. Arnason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon E. Arnason. The network helps show where Jon E. Arnason may publish in the future.
Co-authors
The 25 scholars most cited alongside Jon E. Arnason, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study Hit paper breakdown → | 2020 | 1909 |
| 2 | Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease Hit paper breakdown → | 2007 | 777 |
| 3 | Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial Hit paper breakdown → | 2022 | 580 |
| 4 | Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study Hit paper breakdown → | 2022 | 296 |
| 5 | 2016 | 253 | |
| 6 | 2017 | 160 | |
| 7 | 2012 | 144 | |
| 8 | 2016 | 143 | |
| 9 | 2015 | 123 | |
| 10 | Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001 Hit paper breakdown → | 2023 | 121 |
| 11 | 2018 | 103 | |
| 12 | 2021 | 99 | |
| 13 | 2020 | 94 | |
| 14 | 2021 | 87 | |
| 15 | 2021 | 87 | |
| 16 | 2023 | 73 | |
| 17 | 2001 | 71 | |
| 18 | 2019 | 63 | |
| 19 | 2015 | 59 | |
| 20 | 2017 | 58 |
About Jon E. Arnason
Jon E. Arnason is a scholar working on Genetics, Hematology, Immunology, Oncology and Pathology and Forensic Medicine, having authored 124 papers that have together received 6.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (40 papers), Chronic Lymphocytic Leukemia Research (38 papers), Lymphoma Diagnosis and Treatment (30 papers), Immunotherapy and Immune Responses (17 papers), Immunodeficiency and Autoimmune Disorders (13 papers), Chronic Myeloid Leukemia Treatments (12 papers), Multiple Myeloma Research and Treatments (10 papers) and Immune Cell Function and Interaction (8 papers). The work is most often cited by research in Oncology (3.8k citations), Genetics (1.0k citations), Pathology and Forensic Medicine (1.6k citations), Immunology (1.9k citations) and Hematology (788 citations). Jon E. Arnason has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Tim D. Sparwasser, Christoph Loddenkemper, Alf Hamann, Katharina Lahl, Jennifer Freyer, Gérard Eberl, Jochen Huehn, Hermann Wagner, Jeremy S. Abramson and Jennifer R. Brown. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Blood Advances, British Journal of Haematology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.